Live News REGULATION FLASH L impact Nov 05, 2026, 01:39 AM UTC FDA Grants Orphan Drug Designation to Hutchmed’s Sovleplenib The designation is for treatment of autoimmune hemolytic anemia. SquawkNews Desk